Recurrent & Revision Carpal Tunnel Syndrome (and Endoscopic Release)

Scale. Carpal tunnel release is highly successful, but across pooled series the index operation fails in about 5-10% of cases, and 0.3-7% go on to revision. Individual series report up to 20% persistent or recurrent symptoms and 12% revision. Quote the range rather than the ceiling: the higher figures come from small referred cohorts enriched for difficult cases.

Three patterns. A failed release is not one problem. The time course separates three patterns with different causes, and each needs a different response.

Most failures are an incomplete release or the wrong diagnosis. The two commonest reasons a release "fails" are a transverse carpal ligament not fully divided, classically distally or with the proximal antebrachial fascia left intact, and an incorrect or co-existing diagnosis, where the symptoms were not, or not only, from carpal tunnel compression. Both are identified by careful work-up rather than by re-operating blindly. Genuine recurrence after a symptom-free interval is usually perineural scarring, and it is the group most often considered for revision with neurolysis.

The distal transverse carpal ligament, the antebrachial fascia, the recurrent motor branch and the palmar cutaneous branch are the anatomical causes of failure, and the anatomy is what makes each failure mode make sense. The basic anatomy is developed in Carpal Tunnel Syndrome and Median Nerve Anatomy.

Where the release is left incomplete. The transverse carpal ligament (flexor retinaculum) spans the carpal arch from the scaphoid tubercle and trapezium radially to the pisiform and hook of hamate ulnarly. The parts most commonly under-divided are its distal edge, toward the palm, and the proximal antebrachial fascia. Leaving either gives persistent symptoms.

The recurrent (thenar) motor branch. It usually arises extraligamentously and recurs distal to the ligament. In the subligamentous and transligamentous Lanz variants it runs under or pierces the ligament, and these are the variants at risk during division. Injury causes thenar motor loss, a new or iatrogenic failure.

The palmar cutaneous branch. It arises about 5 cm proximal to the wrist crease and runs between palmaris longus and flexor carpi radialis to the thenar skin. An incision placed too radially or across the crease can injure it, producing a painful neuroma or a numb scar.

The superficial palmar arch. It lies just distal to the ligament's distal edge. It is the structure at risk when chasing a complete distal release, and a reason distal visualisation matters. Mapping each failure to its structure is why the revision field is approached open, for direct visualisation.

View larger

Re-confirm the diagnosis and find the cause. The work-up has four parts:

• History and examination. Was there ever relief? Which symptoms persist, sensory or motor with thenar wasting? Look for scar tenderness, Tinel's and Phalen's signs, and signs of a branch injury or CRPS.
• Electrodiagnostics. Repeat nerve conduction studies and EMG, and compare them with the pre-operative studies.
• Imaging. Ultrasound or MRI of the nerve and canal shows an incomplete release, perineural scar, a reformed ligament or a space-occupying lesion.
• Exclusion of mimics. Cervical radiculopathy, proximal median compression (pronator or lacertus), peripheral polyneuropathy (diabetic, for example) and thoracic outlet syndrome. A double crush may coexist.

What Each Result Actually Changes

Was there ever relief, and for how long? This one question does more work than any investigation, because it separates the two commonest patterns before anything is measured. Return after a symptom-free interval of at least about three months is conventionally taken as recurrence and points to scar; no meaningful relief at any point is persistence and points to an incomplete release or the wrong diagnosis. The three-month figure is a working convention rather than a validated threshold, and a very short interval, which sits awkwardly between the two, is better recorded honestly than forced into a category.

Nerve conduction studies are a trend, not a verdict. Standard median conduction parameters improve after a successful release but usually do not return to normal. In a prospective study of 35 patients, every electrophysiological parameter except conduction-velocity distribution improved significantly after surgery, yet most remained worse than in controls; only quantitative sensory testing fully returned to normal limits, with the residual signs attributed to incomplete recovery in the large fibres. A still-abnormal post-operative study is therefore the expected finding after a technically good release, and is not by itself evidence of failure.

The comparison is what informs. Studies that improved and then deteriorated support recurrence. Studies unchanged from the outset support either an incomplete release or a diagnosis that was never carpal tunnel compression. A study reported without the pre-operative comparison is an incomplete investigation, not a negative one.

A diagnostic corticosteroid injection remains useful after surgery. Meaningful, if temporary, relief from an injection into the canal (10-40 mg methylprednisolone, the dose used in primary disease) indicates the median nerve is still being compressed there, and is one of the better predictors that a complete re-release will help. No response at all should prompt a serious reconsideration of the diagnosis before any second operation.

Not Every Failed Release Returns to Theatre

Where no correctable structural cause is demonstrated, treatment is non-operative:

• A neutral night splint
• Hand therapy with nerve-gliding and scar desensitisation
• Neuropathic pain agents where the picture is predominantly painful
• Treating the mimic that has been uncovered: cervical radiculopathy, proximal median compression, diabetic polyneuropathy, thyroid disease
• Specific management of complex regional pain syndrome if present

Pillar pain and scar tenderness. After a primary release these commonly settle over three to six months on their own. A re-operation performed in that window is being asked to treat a problem that was going to resolve.

Match the operation to the failure. Persistent symptoms from a demonstrably incomplete release are the patients who benefit most: a complete open re-release divides the entire transverse carpal ligament and antebrachial fascia under direct vision, and is the definitive treatment. Recurrent symptoms from perineural scar are treated by complete re-release with external neurolysis, the mainstay for recurrent disease, adding coverage when the nerve is heavily scarred. A new deficit needs assessment for a nerve or branch injury, as in the table above.

Coverage. Wrapping or covering the nerve provides a healthy vascular bed and reduces re-scarring. The options are local fat or muscle flaps (hypothenar fat pad, pronator quadratus) and vascularised soft-tissue flaps; the choice between them is set out in the flap tab below.

The technique. Endoscopic release divides the transverse carpal ligament from beneath, viewing it from inside the canal, through one portal at the distal wrist crease (single-portal, Agee) or through proximal and distal portals (two-portal, Chow).

What it buys. The gain is confined to the early period and is modest but real: a smaller scar, less scar tenderness (the risk of pillar pain is similar), better grip and pinch strength in the early weeks, and return to work earlier by a mean of about eight days (95% CI 2-14) in Cochrane's pooled analysis. Long-term symptom relief and success rates are the same as open release, around 90-95% by six to twelve months. The choice is a trade of early comfort against exposure, not one technique being better.

What it costs. The ligament is divided without the nerve being inspected and without the canal contents available to the surgeon's eye. Transient nerve injury is more frequent than after open release, and the length of the learning curve has not been defined. In the revision setting, scarred or distorted anatomy makes open release the safer choice, and any concern about completeness or nerve injury favours a direct open approach.

Where it must not be used.

• Any previous carpal tunnel surgery, which is why revision is done open. Scar obliterates the plane the cannula is meant to pass through and displaces the nerve from where the endoscope expects it.
• A suspected mass or tenosynovitis needing biopsy or debulking. Endoscopic release can divide the ligament but cannot address, or even see, what is in the canal.
• Distorted anatomy: previous distal radius or carpal fracture, severe wrist arthritis with osteophytes. A known bifid median nerve or persistent median artery is a relative contraindication: the decision is system- and surgeon-dependent, and open release is the conservative choice when imaging shows an unsafe intratunnel path.
• Inadequate visualisation at any point during the case. Failure to see the ligament clearly is an indication to convert to open, not to continue by feel, and the ability to convert is part of consenting for the procedure.

Who does well. Patients with a definable, correctable problem can be revised with confidence. That means persistent symptoms from a demonstrably incomplete release, with objective electrodiagnostic confirmation and a clear anatomical cause, or recurrent symptoms after a genuine symptom-free interval with scar on imaging.

Who does less well. Be cautious, and temper expectations, where there is:

• No prior relief at all with normal or unchanged electrodiagnostics, which suggests the diagnosis was wrong
• Pure pain without nerve-compression signs
• CRPS
• An untreated proximal or double-crush component
• Established thenar wasting, with incomplete motor recovery
• A workers' compensation or litigation context